openPR Logo
Press release

Colorectal Cancer Market Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023) | Leading Key Players are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD

12-12-2018 08:38 AM CET | Health & Medicine

Press release from: Market Data Forecast

/ PR Agency: Market Data Forecast
Colorectal Cancer Market Analysis, Size, Share, Growth,

Colorectal Cancer Market Overview

Though there has been a significant development in science and technology to combat cancer, it continues to threaten lives across the globe. Colorectal cancer, the third most common type of cancer is fast becoming a horrible reality for many.

Colorectal cancer is a sign of unrestrained cell growth, which occurs in the appendix, colon and the rectum region. Some of the generally seen symptoms of colorectal cancer are blood in the stool, fatigue, weight loss, and irregular bowel movements. Colorectal cancer can be recognized with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much cancer has expanded, a combination of chemotherapy, radiation therapy, and targeted therapy is recommended by most oncologists.

Request for Sample @ https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/request-sample

The growth of the Global Colorectal Cancer Market is primarily driven by factors such as rise in pipeline colorectal cancer screening tests, increasing awareness, aging population, and government policies to provide better care for Colorectal Cancer. However, high costs of screening tests and poor availability of proper cancer care in emerging regions are hindering the growth of the market.

Colorectal Cancer Market Forecast Report (2018-2023)

The Global Colorectal Cancer Market worth was $14.91 billion in 2018 and estimated to be growing at a CAGR of 2.60%, to reach $16.95 billion by 2023.

Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/

Colorectal Cancer Market Segmentation

The Global Colorectal Cancer market is classified based on Diagnosis and Treatment. The market for Colorectal Cancer, based on Diagnosis is classified into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, and Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is classified into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.

The market has also been geographically classified into North America, Europe, Asia-Pacific and the Rest of the World. North America accounted for the major share in the global Colorectal Cancer market followed by Asia-Pacific and Europe. However, The Asia-Pacific region is projected to rise at the highest CAGR during the forecast period due to reasons such as increasing participation of several private & public establishments to organize awareness programs on Colorectal Cancer.

Key Developments in the Market

May 2017: Novigenixsigned a distribution agreement with Dr. Risch Medical Laboratory to access the Swiss German market for the colox, its blood based colorectal cancer test

Buy now @ https://www.marketdataforecast.com/cart/buy-now/global-colorectal-cancer-market-612/

Major Players: 

The major companies dominating the Colorectal Cancer market are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.

Customize Report @ https://www.marketdataforecast.com/market-reports/global-colorectal-cancer-market-612/customize-report

The scope of the report:

1. Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the untapped regions.
2. Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
3. Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
4. Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
5. Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
6. A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
7. Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
8. An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

About Us

Market Data Forecast is dedicate working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for different business domains to cater the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: abhishek@marketdataforecast.com

Tel: +1-888-702-9626

Website: www.marketdataforecast.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Market Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023) | Leading Key Players are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD here

News-ID: 1434276 • Views:

More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significant growth rate
Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024. The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations
Antimicrobial Coatings Market expected to witness a significant growth rate of 11% by 2029.
Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029. It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively
End-User Computing Market Sees Explosive Growth Globally
End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period. Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user
Smart Homes Market Size, Share, Growth Report 2024-2029
Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period. Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and

All 5 Releases


More Releases for Colorectal

Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685 This latest report researches the
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @ https://goo.gl/1HQ4Fn . Report Description: Pharmaceutical guide Colorectal Cancer - Pipeline Review H1
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which